Cleo Diagnostics Ltd (ASX:COV)
Australia · Delayed Price · Currency is AUD 0.6500
+0.0250 (4.00%)
Last updated: Apr 28, 2026, 3:07 PM AEST
Cleo Diagnostics Market Cap
Cleo Diagnostics has a market cap or net worth of 85.54 million as of April 28, 2026. Its market cap has increased by 87.51% in one year.
Market Cap
85.54M
Enterprise Value
76.11M
Revenue
2.56M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.65
Market Cap Chart
Since August 15, 2023, Cleo Diagnostics's market cap has increased from 25.70M to 85.54M, an increase of 232.84%. That is a compound annual growth rate of 56.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 85.54M | 3.31% |
| Dec 31, 2025 | 82.80M | 81.51% |
| Dec 31, 2024 | 45.62M | 102.86% |
| Dec 29, 2023 | 22.49M | -12.50% |
| Aug 15, 2023 | 25.70M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aroa Biosurgery | 183.33M |
| EMVision Medical Devices | 167.29M |
| Lumos Diagnostics Holdings | 152.24M |
| SomnoMed | 136.93M |
| Epiminder | 129.81M |
| Compumedics | 56.93M |
| HeraMED | 56.59M |
| Micro-X | 39.24M |